EssilorLuxottica Société anonyme (ESLOF)
OTCMKTS · Delayed Price · Currency is USD
325.00
+16.45 (5.33%)
Jan 6, 2026, 2:44 PM EST
ESLOF Market Cap
ESLOF has a market cap or net worth of $149.42 billion as of January 6, 2026. Its market cap has increased by 35.86% in one year.
Market Cap
149.42B
Enterprise Value
163.27B
Revenue
31.99B
Ranking
n/a
PE Ratio
53.44
Stock Price
$325.00
Market Cap Chart
Since February 11, 1992, ESLOF's market cap has increased from 474.08M to 149.42B, an increase of 31,418.66%. That is a compound annual growth rate of 18.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 142.22B | -2.68% |
| Dec 31, 2025 | 146.14B | 31.46% |
| Dec 31, 2024 | 111.17B | 22.76% |
| Dec 29, 2023 | 90.56B | 14.56% |
| Dec 30, 2022 | 79.05B | -15.86% |
| Dec 31, 2021 | 93.95B | 38.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 719.98M |
| Elite Pharmaceuticals | 537.20M |
| Northwest Biotherapeutics | 397.78M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 342.98M |
| Silence Therapeutics | 290.49M |